Home - Australian Pharmacist

Are unconscious gender biases widening the Australian gender pain gap?

AP Staff - February 21, 2000

CPD

References Filingim R. Individual differences in pain: understanding the mosaic that makes pain personal. Pain 2017;158(Suppl 1):S11–S18. Widemann TH, Edwards RR, Walton DM, et...

A thiazolidinedione for hepatitis B

Dr Esther Lau and Prof Lisa Nissen - January 28, 2000

Clinical

Thiazolidinediones may hold the key to developing a new class of anti-HBV medicines that will cure the chronic infection.

Preparing for the 2024 ‘tripledemic’

Chloe Hava - February 1, 2000

Industry

Now is the time to arm Australians with vaccines, respiratory disease advice, testing and essential medicines to get ahead of respiratory ailment season. The trifecta...

One size does not fit all

Ruth Cooper - October 9, 2000

Practice

When it comes to person-centred care, bespoke tailoring to every patient’s healthcare needs is fundamental.

A good night’s sleep

AP Staff - August 8, 2000

Clinical

References 1. Hillman D, Mitchell S, Streatfeild J, et al. The economic cost of inadequate sleep. Sleep 2018;41(8). Epub 2018 Jun 4. 2. Claughton D. Farmers...

Oral Antihyperglycaemics for COPD exacerbations

A/Prof Esther Lau and Prof Lisa Nissen - May 9, 2000

Clinical

Emerging evidence is pointing to the benefits of ‘novel’ antihyperglycaemics on lung function in COPD patients.

1...284285286...291 Page 285 of 291

Pharmacist of the Year – Ammar Altayib MPS

Lifetime Achievement Award – David North OAM MPS

Early Career Pharmacist of the Year – Lily Pham MPS

Intern of the Year – Peter Figliuzzi

Could Australia follow suit?

What does the TGA advise?

Will GLP-1 RAs be subsidised for weight loss?

What could LGBTQIA+ discrimination look like in a pharmacy setting?

What’s the impact?

What makes a pharmacy a welcoming and safe environment for LGBTQIA+ patients?

What challenges do LGBTQIA+ pharmacists face in the workplace?

Does your pharmacy warrant a ‘Rainbow Tick’?

What’s changing?

When does this change come into effect?

What’s the reason for the change?

If I record in practice management software, do I need to do anything differently?

Will there be further changes to practice software after 1 March?

Will I need to do anything differently if I enter vaccination directly into AIR via PRODA?

Does this mean pharmacists need to ask about pregnancy for every vaccination event?

What impact does a Wegovy have on cardiovascular risk?

What makes a patient eligible for Wegovy for cardiovascular disease?

What other cardiovascular risk factors does Wegovy help to mitigate?

Has a submission been made to PBAC?

What are the benefits for high-risk CVD patients with multimorbidities?

How long should cardiovascular patients stay on Wegovy?

Should other cardiovascular medicines be titrated if Wegovy is initiated?

What do patients need to know about adverse effects?

What complimentary lifestyle advice should pharmacists provide?

Pharmacist of the Year – Ammar Altayib MPS

Lifetime Achievement Award – David North OAM MPS

Early Career Pharmacist of the Year – Lily Pham MPS

Intern of the Year – Peter Figliuzzi

Could Australia follow suit?

What does the TGA advise?

Will GLP-1 RAs be subsidised for weight loss?

What could LGBTQIA+ discrimination look like in a pharmacy setting?

What’s the impact?

What makes a pharmacy a welcoming and safe environment for LGBTQIA+ patients?

What challenges do LGBTQIA+ pharmacists face in the workplace?

Does your pharmacy warrant a ‘Rainbow Tick’?

What’s changing?

When does this change come into effect?

What’s the reason for the change?

If I record in practice management software, do I need to do anything differently?

Will there be further changes to practice software after 1 March?

Will I need to do anything differently if I enter vaccination directly into AIR via PRODA?

Does this mean pharmacists need to ask about pregnancy for every vaccination event?

What impact does a Wegovy have on cardiovascular risk?

What makes a patient eligible for Wegovy for cardiovascular disease?

What other cardiovascular risk factors does Wegovy help to mitigate?

Has a submission been made to PBAC?

What are the benefits for high-risk CVD patients with multimorbidities?

How long should cardiovascular patients stay on Wegovy?

Should other cardiovascular medicines be titrated if Wegovy is initiated?

What do patients need to know about adverse effects?

What complimentary lifestyle advice should pharmacists provide?

Pharmacist of the Year – Ammar Altayib MPS

Lifetime Achievement Award – David North OAM MPS

Early Career Pharmacist of the Year – Lily Pham MPS

Intern of the Year – Peter Figliuzzi

Could Australia follow suit?

What does the TGA advise?

Will GLP-1 RAs be subsidised for weight loss?

What could LGBTQIA+ discrimination look like in a pharmacy setting?

What’s the impact?

What makes a pharmacy a welcoming and safe environment for LGBTQIA+ patients?

What challenges do LGBTQIA+ pharmacists face in the workplace?

Does your pharmacy warrant a ‘Rainbow Tick’?

What’s changing?

When does this change come into effect?

What’s the reason for the change?

If I record in practice management software, do I need to do anything differently?

Will there be further changes to practice software after 1 March?

Will I need to do anything differently if I enter vaccination directly into AIR via PRODA?

Does this mean pharmacists need to ask about pregnancy for every vaccination event?

What impact does a Wegovy have on cardiovascular risk?

What makes a patient eligible for Wegovy for cardiovascular disease?

What other cardiovascular risk factors does Wegovy help to mitigate?

Has a submission been made to PBAC?

What are the benefits for high-risk CVD patients with multimorbidities?